SEC-Show

BALCHEM CORP filed this DEF 14A on April 26, 2024

Back to Results Entire Filing Printer Friendly Outline

BALCHEM CORP - DEF 14A - 20240426 - OPTIONS

Executive Compensation

2023 Grants of Plan-Based Awards

Name	Grant Date	Grant Type	Estimated Future Payouts Under Non-Equity Incentive Plan Awards(1)			Estimated Future Payouts Under Equity Incentive Plan Awards(2)			All Other Stock Awards: Number of Shares of Stock (#)	All Other: Number of Securities Underlying Stock Options (#)	Exercise Price of Stock Option(3) ($/Share)	Grant Date Fair Value of Stock and Option Awards(4) ($)
Name	Grant Date	Grant Type	Threshold	Target	Maximum	Threshold (#)	Target (#)	Maximum (#)	All Other Stock Awards: Number of Shares of Stock (#)		Exercise Price of Stock Option(3) ($/Share)
Ted Harris		ICP	$0	$1,270,500	$2,541,000
	02/08/2023	Performance Shares				5,775	11,550	23,100
	02/08/2023	Time-Based Restricted Shares							6,280
	02/08/2023	Stock Options								21,200	$138.09
												$3,469,079
C. Martin Bengtsson		ICP	$0	$342,769	$685,538
	02/08/2023	Performance Shares				1,490	2,980	5,960
	02/08/2023	Time-Based Restricted Shares							1,620
	02/08/2023	Stock Options								5,500	$138.09
												$896,255
Frederic Boned		ICP	$0	$216,382	$432,765
	02/08/2023	Performance Shares				710	1,420	2,840
	02/08/2023	Time-Based Restricted Shares							770
	02/08/2023	Stock Options								2,600	$138.09
												$426,007
Hatsuki Miyata		ICP	$0	$217,935	$435,870
	02/08/2023	Performance Shares				710	1,420	2,840
	02/08/2023	Time-Based Restricted Share Awards							770
	02/08/2023	Stock Options								2,600	$138.09
												$427,007
Martin Reid		ICP	$0	$227,460	$454,920
	02/08/2023	Performance Shares				745	1,490	2,980
	02/08/2023	Time-Based Restricted Shares							810
	02/08/2023	Stock Options								2,800	$138.09
												$450,173

(1)	The maximum amounts equal 200% of target. Additional information regarding the design of the ICP is included in the Compensation Discussion and Analysis.

(2)

The target number of shares shown in the table reflects the number of shares of our Common Stock earned if performance is achieved at target levels. All shares will be awarded net of applicable tax withholding. Dividend equivalents accrue during the performance cycle and will be paid out in shares, net of applicable tax withholding, based on the actual number of shares earned for the performance cycle, if any.

(3)	The exercise price equals the closing price of our Common Stock on the grant date except as otherwise indicated.

(4)	The amounts represent the grant date fair value of the awards as computed in accordance with FASB ASC Topic 718.